These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 30672777)
21. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239 [TBL] [Abstract][Full Text] [Related]
22. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway. Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
24. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338 [TBL] [Abstract][Full Text] [Related]
25. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathway. Wang M; Wang L; He X; Zhang J; Zhu Z; Zhang M; Li X Int J Oncol; 2020 Jan; 56(1):327-336. PubMed ID: 31789385 [TBL] [Abstract][Full Text] [Related]
26. Six3, a medaka homologue of the Drosophila homeobox gene sine oculis is expressed in the anterior embryonic shield and the developing eye. Loosli F; Köster RW; Carl M; Krone A; Wittbrodt J Mech Dev; 1998 Jun; 74(1-2):159-64. PubMed ID: 9651515 [TBL] [Abstract][Full Text] [Related]
27. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888 [TBL] [Abstract][Full Text] [Related]
28. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B. Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628 [TBL] [Abstract][Full Text] [Related]
29. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989 [TBL] [Abstract][Full Text] [Related]
30. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling. Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429 [TBL] [Abstract][Full Text] [Related]
31. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis. Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161 [TBL] [Abstract][Full Text] [Related]
32. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
33. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells. Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma. Li Y; Jiang X; Yan X; Wang Y Thorac Cancer; 2021 Mar; 12(6):752-759. PubMed ID: 33481352 [TBL] [Abstract][Full Text] [Related]
35. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600 [TBL] [Abstract][Full Text] [Related]
36. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Wang G; Sun J; Zhao H; Li H Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517 [TBL] [Abstract][Full Text] [Related]
40. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis]. Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]